Garcia-Albeniz X, Hsu J, Etzioni R, Chan JM, Shi J, Dickerman B, Hernan MA. Prostate-specific antigen screening and prostate cancer mortality: an emulation of target trials in US Medicare. JCO Clin Cancer Inform. 2024 Aug;8:e240094. doi: 10.1200/CCI.24.00094
Lopez LR, Barlogio CJ, Broberg CA, Wang J, Arthur JC. A nadA mutation confers nicotinic acid auxotrophy in pro-carcinogenic intestinal escherichia coli NC101. Front Microbiol. 2021 Jun 2;12:670005. doi: 10.3389/fmicb.2021.670005
Brown TM, Horblyuk RV, Grotzinger KM, Matzdorff AC, Pashos CL. Patient-reported treatment burden of chronic immune thrombocytopenia therapies. BMC Blood Disord. 2012 Mar 1;12(1):2.